[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO982311D0 - Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt - Google Patents

Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt

Info

Publication number
NO982311D0
NO982311D0 NO982311A NO982311A NO982311D0 NO 982311 D0 NO982311 D0 NO 982311D0 NO 982311 A NO982311 A NO 982311A NO 982311 A NO982311 A NO 982311A NO 982311 D0 NO982311 D0 NO 982311D0
Authority
NO
Norway
Prior art keywords
prevention
compositions
treatment
methods
oral mucositis
Prior art date
Application number
NO982311A
Other languages
English (en)
Other versions
NO982311L (no
Inventor
Deborah A Steinberg
De Hwa Chao
David Loury
Roger Cherng Fu
Chee Liang Gu
Conway C Chang
John C Fiddes
Original Assignee
Intrabiotics Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrabiotics Pharmaceuticals filed Critical Intrabiotics Pharmaceuticals
Publication of NO982311D0 publication Critical patent/NO982311D0/no
Publication of NO982311L publication Critical patent/NO982311L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO982311A 1995-11-22 1998-05-20 Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt NO982311L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56234695A 1995-11-22 1995-11-22
US64981196A 1996-05-17 1996-05-17
US69092196A 1996-08-01 1996-08-01
US08/752,852 US5994306A (en) 1995-11-22 1996-11-21 Fine-tuned protegrins
PCT/US1996/018845 WO1997018827A1 (en) 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis

Publications (2)

Publication Number Publication Date
NO982311D0 true NO982311D0 (no) 1998-05-20
NO982311L NO982311L (no) 1998-07-22

Family

ID=27415886

Family Applications (2)

Application Number Title Priority Date Filing Date
NO982310A NO982310L (no) 1995-11-22 1998-05-20 Protegriner
NO982311A NO982311L (no) 1995-11-22 1998-05-20 Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO982310A NO982310L (no) 1995-11-22 1998-05-20 Protegriner

Country Status (12)

Country Link
US (1) US5994306A (no)
EP (1) EP0862448A4 (no)
JP (1) JP2001520639A (no)
KR (1) KR19990071546A (no)
CN (1) CN1251041A (no)
AU (1) AU720467B2 (no)
BR (1) BR9611565A (no)
CZ (1) CZ159198A3 (no)
HU (1) HUP0104431A2 (no)
NO (2) NO982310L (no)
PL (1) PL336763A1 (no)
WO (2) WO1997018827A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US6159936A (en) * 1993-07-20 2000-12-12 The Regents Of The University Of California Compositions and methods for treating and preventing microbial and viral infections
US6307016B1 (en) * 1995-07-06 2001-10-23 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
USRE38828E1 (en) * 1995-07-06 2005-10-11 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
KR100314721B1 (ko) * 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
CA2327329A1 (en) * 1998-03-12 1999-09-16 Georgetown University Medical Center Cholesterol recognition sequence
US20020102604A1 (en) 1999-12-08 2002-08-01 Milne Edwards Jean-Baptiste Dumas Full-length human cDNAs encoding potentially secreted proteins
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
EP1089755B1 (en) * 1998-06-26 2004-02-18 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
EP0974360A3 (en) * 1998-06-26 2000-03-29 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
ES2186377T3 (es) * 1998-07-02 2003-05-01 Stichting Skeletal Tissue Engi Cemento para huesos peptidos antimicrobianos.
AU5006499A (en) * 1998-07-23 2000-02-14 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the treatment or prevention of pulmonary infections
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
EP1240180A2 (en) * 1999-12-21 2002-09-18 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
BR0001870B1 (pt) * 2000-05-29 2014-02-25 Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
GB0031425D0 (en) * 2000-12-22 2001-02-07 Amoebics Ltd Antibacterial treatments
KR100738362B1 (ko) * 2001-03-19 2007-07-12 재단법인서울대학교산학협력재단 신규한 디아민디티올 유도체 및 그의 방사성 레늄 또는방사성 테크네슘 착체； 그리고, 그의 방사성 레늄 착체와리피오돌을 포함하는 간암 치료용 조성물 및 그의 제조용키트
JP2004534084A (ja) * 2001-06-22 2004-11-11 ザ ホスピタル フォー シック チルドレン 抗菌ペプチド
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
WO2003062266A2 (en) * 2002-01-22 2003-07-31 Intrabiotics Pharmaceuticals, Inc. Hybrid synthetic method for antimicrobial peptides
JP4472998B2 (ja) 2002-04-22 2010-06-02 ダウ グローバル テクノロジーズ インコーポレイティド 低コストのペプチド製造
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
US20060148690A1 (en) * 2002-07-08 2006-07-06 Lydie Bougueleret Secreted peptides
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
US7846895B2 (en) 2006-09-06 2010-12-07 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
TWI394578B (zh) * 2009-01-09 2013-05-01 Academia Sinica 抗菌蛋白之新用途
US20100202983A1 (en) * 2009-02-09 2010-08-12 Jernberg Gary R Selectively targeted antimicrobials for the treatment of periodontal disease
EP2709619B1 (en) 2011-05-16 2017-10-11 Cellceutix Corporation Compounds for use in treatment of mucositis
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US9925223B2 (en) 2012-09-25 2018-03-27 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
CN103623391B (zh) * 2013-10-10 2014-12-31 中山大学 抗菌肽Protegrin-1在防治猪蓝耳病中的应用
EP3062889A2 (en) 2013-11-01 2016-09-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103936827B (zh) * 2014-04-22 2015-10-14 福州大学 一种韭菜籽抗菌三肽及其制备方法与应用
CN105175509A (zh) * 2015-10-19 2015-12-23 河南科技学院 一种抗菌肽xyz-1及其应用
CN108524911B (zh) * 2018-02-27 2022-03-08 成都山信药业有限公司 Protegrin-1抗菌肽衍生物在制备抗口腔致病菌药物中的用途
WO2020081097A1 (en) * 2018-10-19 2020-04-23 Riptide Bioscience, Inc. Antimicrobial peptides and methods of using the same
US20220054562A1 (en) 2018-12-28 2022-02-24 General Probiotics, Inc. Combinations of engineered antimicrobial probiotics for treatment of gastrointestinal tract pathogens
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
CN113975373A (zh) * 2021-11-18 2022-01-28 宁波市眼科医院 眼用制剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4705777A (en) * 1985-02-25 1987-11-10 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5338724A (en) * 1986-11-26 1994-08-16 Cornell Research Foundation, Inc. Antimicrobial proteins, compositions containing same and uses thereof
US5087569A (en) * 1986-11-26 1992-02-11 Cornell Research Foundation, Inc. And The Rockefeller University Antimicrobial proteins, compositions containing same and uses thereof
US5126257A (en) * 1986-11-26 1992-06-30 Cornell Research Foundation Antimicrobial proteins, compositions containing same and uses thereof
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
US5607916A (en) * 1989-07-05 1997-03-04 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
AU667479B2 (en) * 1991-06-12 1996-03-28 Magainin Pharmaceuticals, Inc. Treating the oral cavity with ion-channel forming peptides
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
JPH08501070A (ja) * 1992-05-26 1996-02-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗生物クリプトジンペプチド及びその使用方法
EP0746605A4 (en) * 1992-07-17 1997-04-16 Panorama Res Inc CATIONIC MAMMAL PROTEINS, WHICH HAVE A LIPOPOLYSACCHARID BINDING ACTIVITY AND ANTI-COAGLING ACTIVITY
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
WO1994028921A1 (en) * 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
HU217442B (hu) * 1993-10-14 2000-01-28 Seikagaku Corp. Polipeptidek és ezeket tartalmazó HIV-ellenes hatású gyógyászati készítmények
US5804553A (en) * 1994-04-05 1998-09-08 University Of California Prophenins - antibiotic peptides
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
EP0836617A4 (en) * 1995-07-06 2000-06-28 Intrabiotics Pharmaceuticals PAREVINES AND TACHYTEGRINES

Also Published As

Publication number Publication date
NO982310L (no) 1998-07-22
NO982310D0 (no) 1998-05-20
KR19990071546A (ko) 1999-09-27
PL336763A1 (en) 2000-07-17
CN1251041A (zh) 2000-04-19
WO1997018826A1 (en) 1997-05-29
JP2001520639A (ja) 2001-10-30
HUP0104431A2 (hu) 2002-03-28
CZ159198A3 (cs) 1998-10-14
NO982311L (no) 1998-07-22
EP0862448A4 (en) 1999-03-31
WO1997018827A1 (en) 1997-05-29
AU7739496A (en) 1997-06-11
US5994306A (en) 1999-11-30
AU720467B2 (en) 2000-06-01
EP0862448A1 (en) 1998-09-09
BR9611565A (pt) 1999-12-28

Similar Documents

Publication Publication Date Title
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
FI964874A (fi) Vihannesten käsittely
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
PT1093815E (pt) Formulacao oral de 2-metil-tieno-benzodiazepina
NO992641D0 (no) Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
BR9609132A (pt) Composicão e método de tratamento de semente
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
EP0808324A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES
BR9604959A (pt) Composição e método para o tratamento de desensibilização de dentes
FI941826A (fi) Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
NO965563D0 (no) Behandling og profylakse av osteoporese
UA28054C2 (uk) Кондитерський виріб та спосіб його одержання
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
NO971900D0 (no) Blandinger og behandling av multippel sklerose
DE69620642D1 (de) Reiningungsverfahren und-zusammensetzung
NO983512D0 (no) Midler for behandling og forhindring av AIDS
DE59504148D1 (de) Mund- und zahnpflegemittel
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer